Literature DB >> 16551621

Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells.

Paulo Matos1, Peter Jordan.   

Abstract

Increased NF-kappaB-mediated transcription has been extensively linked to tumorigenesis and can be stimulated by deregulated Rac1 signaling. For example, the overexpression of Rac1b, a highly activated splicing variant of Rac1 with increased expression in colorectal tumors, stimulates NF-kappaB-mediated G1/S progression and cell survival, and was shown to promote cell transformation and epithelial-mesenchymal transition. Here we show evidence of further complexity between Rac1b and Rac1 signaling toward NF-kappaB in colorectal cells. Consistent with data from other cell types we demonstrate that both Rac1 and Rac1b stimulate transcriptional activation from reporter genes driven by NF-kappaB motifs or the cyclin D1 promoter in an IkappaBalpha- and reactive oxygen species-dependent manner. However, we found that in colorectal cells Rac1, but not Rac1b, induces nuclear translocation of RelB and p52, activates transcription from a RelB-specific reporter, and can be isolated in a complex with endogenous RelB and its inhibitor NF-kappaB2/p100. In addition, Rac1 colocalizes at the plasma membrane with RelB, p100, and cullin-1, a core subunit of the E3 ubiquitin ligase that marks p100 for proteolytic processing to p52. Interestingly, this Rac1-specific pathway is not mediated via the production of reactive oxygen species. These data provide evidence that both Rac1 and Rac1b activate the canonical RelA-IkappaBalpha pathway, whereas Rac1 further stimulates NF-kappaB by inducing the RelB-NF-kappaB2/p100 pathway. The RelB pathway was reported to down-regulate canonical NF-kappaB activation during the inflammatory response, suggesting that increased levels of Rac1b in colorectal tumors may promote tumorigenesis by stimulating canonical NF-kappaB signaling while circumventing a negative feedback from the RelB pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551621     DOI: 10.1074/jbc.M513243200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Ubiquitination: Added complexity in Ras and Rho family GTPase function.

Authors:  Michelle de la Vega; James F Burrows; James A Johnston
Journal:  Small GTPases       Date:  2011-07-01

2.  The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression.

Authors:  Vânia Gonçalves; Paulo Matos; Peter Jordan
Journal:  RNA       Date:  2008-10-24       Impact factor: 4.942

3.  Perturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b.

Authors:  Anjaruwee S Nimnual; Laura J Taylor; Marian Nyako; Hao-Hsuan Jeng; Dafna Bar-Sagi
Journal:  Small GTPases       Date:  2010-09

Review 4.  Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).

Authors:  Giuseppe Biamonti; Serena Bonomi; Stefania Gallo; Claudia Ghigna
Journal:  Cell Mol Life Sci       Date:  2012-02-19       Impact factor: 9.261

5.  The 19-amino acid insertion in the tumor-associated splice isoform Rac1b confers specific binding to p120 catenin.

Authors:  Lidiya Orlichenko; Rory Geyer; Masahiro Yanagisawa; Davitte Khauv; Evette S Radisky; Panos Z Anastasiadis; Derek C Radisky
Journal:  J Biol Chem       Date:  2010-04-15       Impact factor: 5.157

6.  The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression.

Authors:  Larissa Kotelevets; Francine Walker; Godefroy Mamadou; Thérèse Lehy; Peter Jordan; Eric Chastre
Journal:  Oncogene       Date:  2018-07-09       Impact factor: 9.867

Review 7.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

8.  Rac1 signaling modulates BCL-6-mediated repression of gene transcription.

Authors:  Patrícia Barros; Peter Jordan; Paulo Matos
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

Review 9.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

10.  Heat-labile enterotoxin-induced activation of NF-κB and MAPK pathways in intestinal epithelial cells impacts enterotoxigenic Escherichia coli (ETEC) adherence.

Authors:  Xiaogang Wang; Xiaofei Gao; Philip R Hardwidge
Journal:  Cell Microbiol       Date:  2012-04-16       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.